Home    中文  
 
  • Search
  • lucene Search
  • Citation
  • Fig/Tab
  • Adv Search
Just Accepted  |  Current Issue  |  Archive  |  Featured Articles  |  Most Read  |  Most Download  |  Most Cited

Chinese Journal of Clinicians(Electronic Edition) ›› 2017, Vol. 11 ›› Issue (21): 2380-2382. doi: 10.3877/cma.j.issn.1674-0785.2017.21.007

Special Issue:

• Review • Previous Articles     Next Articles

Progress in research of urinary tract infection in postmenopausal women

Lu Wang1, Hongyao Liu2,()   

  1. 1. Shanxi Medical University, Taiyuan 030001, China
    2. Department of Urology, Shanxi Academy of Medical Sciences, Shanxi Dayi Hospital, Taiyuan 030012, China
  • Received:2017-04-06 Online:2017-11-01 Published:2017-11-01
  • Contact: Hongyao Liu
  • About author:
    Corresponding author: Liu Hongyao, Email:

Abstract:

Urinary tract infection (UTI) is one of the most common infectious diseases in the world, and the UTI rate ranks second only to that of respiratory infection. Postmenopausal women are a special population, and UTI in this population presents the features of persistence and high recurrence. So far, there have been few effective strategies available for the prevention and treatment of UTI in postmenopausal women. This paper, based on the literature, discusses the effectiveness and safety of estrogen supplementation, lactobacilli, and antibiotics, alone or in combination, in the prevention and treatment of UTI in postmenopausal women. At present, antibiotics and estrogen are the main treatments for preventing and treating UTI in postmenopausal women. However, new clinical drugs or experimental drugs are under development and trial, which may improve the treatment of UTI in postmenopausal women.

Key words: Postmenopausal women, Urinary tract infection, Lactobacillus, Prevention

京ICP 备07035254号-20
Copyright © Chinese Journal of Clinicians(Electronic Edition), All Rights Reserved.
Tel: 010-57830845 E-mail: zhlcyszz@cma.org.cn
Powered by Beijing Magtech Co. Ltd